GTx: Clinical Trials

4 completed, 1 withdrawn. 5 Phase 3.

By phase and status

Phase	Trials	Status
Phase 3	5	Completed 4, Withdrawn 1

Follow GTx: new trials by email

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum GTx-024, placebo - Muscle Wasting, Non-Small Cell Lung Cancer	Phase 3	Completed	GTx	330	2011-07-01	2020-11-09
Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) GTx-024, placebo - Muscle Wasting, Non Small Cell Lung Cancer	Phase 3	Completed	GTx	321	2011-07-01	2016-03-03
Efficacy and Safety Study of Toremifene Citrate for the Reduction in the Risk of New Bone Fracture Occurrences in Men With Prostate Cancer Toremifene - Risk of Bone Fracture Occurrences	Phase 3	Withdrawn	GTx		2011-03-01	2013-11-15
Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia) Toremifene 20 mg, Placebo - Preneoplastic Conditions, Prostatic Intraepithelial Neoplasia	Phase 3	Completed	GTx	1589	2005-01-01	2023-06-12
Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy Toremifene Citrate - Prostate Cancer, Osteoporosis	Phase 3	Completed	GTx	1200	2003-10-01	2013-11-15

Conditions studied

Carcinoma, Non-Small-Cell Lung (2)  ·  Fractures, Bone (2)  ·  Muscular Atrophy (2)  ·  Prostatic Neoplasms (2)  ·  Bone Diseases, Metabolic (1)  ·  Neoplasms (1)  ·  Osteoporosis (1)  ·  Precancerous Conditions (1)  ·  Prostatic Intraepithelial Neoplasia (1)

Interventions

Toremifene (3)  ·  ostarine (2)

Countries

United States (5)  ·  Argentina (1)  ·  Canada (1)  ·  Mexico (1)

Top investigators

Mitchell Steiner, M.D. (1)  ·  Mitchell Steiner, MD (1)  ·  Samir Taneja, MD (1)

Results publications

PMID 27138015, PMID 22245322, PMID 23234631, PMID 23295793